DEAE-dextran significantly enhances the infectivity of Foot-and-Mouth Disease Virus RNA in calf-kidney cultures, enabling an ultrasensitive plaque assay.
Answers are grounded in this paper and cite their sources.
Facilitates ultrasensitive viral RNA assays in vitro; leaves open translation to clinical diagnostics or in vivo models.
Foot-and-mouth disease virus RNA infectivity for calf-kidney cultures was 102- to 107-fold higher in the presence of DEAE-dextran than in its absence. By comparison, this polycation had no effect on the sensitivity of the plaque assay of the intact virus. At an optimum concentration of DEAE-dextran of about 1000 μg/ml, the infectivity of different lots of RNA ranged from 10-2 to 102 times that of the virus. A linear relationship between plaque numbers and dilution was observed, and the assay was highly reproducible. DEAE-dextran did not raise the temperature of half-melting of the RNA.
No takes yet. Share an insight, caveat, or question.
H. L. Bachrach (1966) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: